84.98
price up icon1.13%   0.955
 
loading
Precedente Chiudi:
$84.03
Aprire:
$84.49
Volume 24 ore:
704.55K
Relative Volume:
0.20
Capitalizzazione di mercato:
$33.32B
Reddito:
$4.15B
Utile/perdita netta:
$535.20M
Rapporto P/E:
63.42
EPS:
1.34
Flusso di cassa netto:
$575.20M
1 W Prestazione:
+0.24%
1M Prestazione:
+6.23%
6M Prestazione:
-2.42%
1 anno Prestazione:
-23.89%
Intervallo 1D:
Value
$84.25
$85.65
Intervallo di 1 settimana:
Value
$83.23
$85.90
Portata 52W:
Value
$57.52
$113.28

Dexcom Inc Stock (DXCM) Company Profile

Name
Nome
Dexcom Inc
Name
Telefono
(858) 200-0200
Name
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Dipendente
10,300
Name
Cinguettio
@dexcom
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
DXCM's Discussions on Twitter

Confronta DXCM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
DXCM
Dexcom Inc
84.97 33.46B 4.15B 535.20M 575.20M 1.34
Medical Devices icon
ABT
Abbott Laboratories
124.88 229.71B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.78 154.35B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
393.19 149.60B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.06 114.97B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.52 45.92B 5.54B 4.18B 623.10M 7.00

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-16 Iniziato Truist Buy
2025-05-30 Iniziato Goldman Buy
2025-04-10 Iniziato Mizuho Outperform
2025-02-03 Aggiornamento Redburn Atlantic Neutral → Buy
2025-01-16 Aggiornamento Robert W. Baird Neutral → Outperform
2024-07-26 Downgrade JP Morgan Overweight → Neutral
2024-07-26 Downgrade Robert W. Baird Outperform → Neutral
2024-05-30 Iniziato Redburn Atlantic Neutral
2024-03-12 Iniziato RBC Capital Mkts Outperform
2023-05-30 Ripresa Morgan Stanley Equal-Weight
2023-04-17 Aggiornamento Raymond James Outperform → Strong Buy
2023-03-29 Iniziato UBS Buy
2023-01-26 Iniziato Wolfe Research Outperform
2022-10-18 Iniziato Barclays Equal Weight
2022-10-12 Iniziato Jefferies Buy
2022-07-15 Iniziato Bernstein Outperform
2022-03-02 Ripresa BofA Securities Buy
2022-02-03 Aggiornamento BTIG Research Neutral → Buy
2022-01-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-01-07 Aggiornamento Guggenheim Neutral → Buy
2021-10-18 Downgrade Guggenheim Buy → Neutral
2021-07-21 Ripresa Cowen Outperform
2021-05-28 Aggiornamento Wells Fargo Underweight → Equal Weight
2021-05-25 Iniziato Barclays Overweight
2021-04-15 Iniziato Atlantic Equities Overweight
2021-01-06 Aggiornamento UBS Neutral → Buy
2020-10-02 Downgrade Wells Fargo Equal Weight → Underweight
2020-05-27 Reiterato Piper Sandler Overweight
2020-05-14 Iniziato Wells Fargo Equal Weight
2020-03-05 Iniziato Citigroup Buy
2019-11-07 Reiterato Canaccord Genuity Buy
2019-11-07 Aggiornamento Guggenheim Neutral → Buy
2019-10-23 Iniziato Stifel Buy
2018-11-28 Iniziato UBS Neutral
2018-10-19 Aggiornamento Goldman Sell → Neutral
2018-09-12 Aggiornamento Northland Capital Under Perform → Market Perform
2018-08-02 Reiterato Canaccord Genuity Buy
2018-07-02 Aggiornamento Raymond James Mkt Perform → Outperform
2018-06-08 Aggiornamento JP Morgan Neutral → Overweight
2018-05-11 Iniziato BofA/Merrill Buy
2018-05-03 Reiterato Canaccord Genuity Buy
2018-04-04 Iniziato Goldman Sell
2018-04-04 Iniziato Guggenheim Neutral
2018-03-23 Aggiornamento Robert W. Baird Neutral → Outperform
2018-01-04 Downgrade Northland Capital Market Perform → Under Perform
2017-09-28 Reiterato Wedbush Outperform
Mostra tutto

Dexcom Inc Borsa (DXCM) Ultime notizie

pulisher
08:20 AM

Is DexCom Inc. a good long term investmentUnmatched profit growth - jammulinksnews.com

08:20 AM
pulisher
Jul 21, 2025

What drives DexCom Inc. stock priceConsistent high-performance stocks - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about DexCom Inc. stockMassive portfolio appreciation - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

DexCom Inc. Stock Analysis and ForecastUnmatched profit potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

DexCom: Delivering Consistent Growth (NASDAQ:DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Still Too Pricey? Dexcom’s Double-Digit Growth May Not Be Enough (DXCM) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Are Medical Stocks Lagging DexCom (DXCM) This Year? - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years - AOL.com

Jul 20, 2025
pulisher
Jul 18, 2025

Dexcom recalls 19 models of glucose monitoring receivers - Modern Healthcare

Jul 18, 2025
pulisher
Jul 18, 2025

Dexcom’s Recall of Certain CGM Receivers is Class I - Medical Product Outsourcing

Jul 18, 2025
pulisher
Jul 17, 2025

Foletta sells Dexcom (DXCM) shares worth $234,216 - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Foletta sells Dexcom (DXCM) shares worth $234,216 By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

FDA updates recall of certain Dexcom CGM speakers (DXCM) - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

Assessing the Impact of Dexcom's Critical Device Recall on Its Market Position and Investor Sentiment - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Dexcom recalls glucose monitor receivers due to alert failure risk - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Dexcom recalls glucose monitor receivers due to alert failure risk By Investing.com - Investing.com UK

Jul 17, 2025
pulisher
Jul 17, 2025

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews - The News-Gazette

Jul 17, 2025
pulisher
Jul 16, 2025

DexCom (DXCM) Target Price Raised by Mizuho Analyst | DXCM Stock News - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Analyst recommendations: Airbnb, Dexcom, Gitlab, AMD, Citigroup… - MarketScreener

Jul 16, 2025
pulisher
Jul 15, 2025

Morgan Stanley Adjusts DexCom Price Target to $89 From $82, Maintains Equal Weight Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Beyond The Numbers: 8 Analysts Discuss DexCom Stock - Benzinga

Jul 15, 2025
pulisher
Jul 14, 2025

DexCom (DXCM) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

When Should You Buy DexCom, Inc. (NASDAQ:DXCM)? - 富途牛牛

Jul 14, 2025
pulisher
Jul 14, 2025

How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga

Jul 14, 2025
pulisher
Jul 14, 2025

DexCom, Inc. (DXCM) Stock Analysis: Evaluating a 18.25% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Jul 14, 2025
pulisher
Jul 11, 2025

Ravens’ Mark Andrews leads first Dexcom U Signing Day Camp, inspiring young athletes with diabetes - WMAR 2 News Baltimore

Jul 11, 2025
pulisher
Jul 09, 2025

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock. - Barron's

Jul 09, 2025
pulisher
Jul 08, 2025

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day - Investegate

Jul 08, 2025
pulisher
Jul 07, 2025

What You Need to Know Ahead of DexCom’s Earnings Release - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

What You Need To Know Ahead Of DexCom’s Earnings Release - Barchart.com

Jul 07, 2025
pulisher
Jul 04, 2025

Oppenheimer Reaffirms DexCom Buy Rating Amid HHS Wearables Push - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

3 Reasons Growth Investors Will Love DexCom (DXCM) - Yahoo Finance

Jul 02, 2025
pulisher
Jul 01, 2025

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time. - BioSpace

Jul 01, 2025
pulisher
Jun 30, 2025

DexCom (DXCM) Leads Healthcare Sector Gains - GuruFocus

Jun 30, 2025
pulisher
Jun 28, 2025

15 Best Fundamental Stocks to Buy According to Hedge Funds - Insider Monkey

Jun 28, 2025
pulisher
Jun 27, 2025

Here's Why DexCom (DXCM) is a Strong Momentum Stock - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

DexCom’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Can DexCom’s Stock Keep Rising? - timothysykes.com

Jun 24, 2025
pulisher
Jun 24, 2025

Abbott stock DexCom stock gain on RFK Jr. comments (DXCM) - Seeking Alpha

Jun 24, 2025
pulisher
Jun 21, 2025

Dexcom shares U.S. report on CGM benefits for type 2 diabetes - MassDevice

Jun 21, 2025
pulisher
Jun 20, 2025

DXCM's Access Gains and Operational Strength Offset Margin Pressures - TradingView

Jun 20, 2025
pulisher
Jun 18, 2025

Dexcom EVP Brown sells $41k in shares - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault' - inkl

Jun 18, 2025

Dexcom Inc Azioni (DXCM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Dexcom Inc Azioni (DXCM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Brown Michael Jon
EVP, Chief Legal Officer
Jul 15 '25
Sale
86.03
500
43,015
94,602
$74.30
price up icon 0.49%
medical_devices PHG
$24.87
price up icon 1.34%
medical_devices STE
$224.05
price up icon 0.52%
medical_devices EW
$76.38
price down icon 0.30%
$281.58
price up icon 0.66%
Capitalizzazione:     |  Volume (24 ore):